Gene therapy for brain tumor shows promising early results in humans

by Ann Megdell – Michigan Medicine

A study from the University of Michigan Department of Neurosurgery and Rogel Cancer Center shows promising early results that a therapy combining cell-killing and immune-stimulating drugs are safe and effective in extending survival for patients with gliomas, a highly aggressive form of brain cancer.

The study was published in The Lancet Oncology.

Click here to read the full article

Related posts:

A New CRISPR Cancer Treatment Has Been Tested On Humans For The First Time – And The Results Are Promising Brain tumor organoids accurately model patient response to CAR T cell therapy New study shows promising evidence for sickle cell gene therapy